Asge Standards of Practice C. et al. ASGE guideline on screening and surveillance of Barrett’s esophagus. Gastrointest Endosc. 2019;90:335–359 e2.

Killcoyne S, Fitzgerald RC. Evolution and progression of Barrett’s oesophagus to oesophageal cancer. Nat Rev Cancer. 2021;21:731–741.

Article  CAS  PubMed  Google Scholar 

Kerkhof M et al. Grading of dysplasia in Barrett’s oesophagus: substantial interobserver variation between general and gastrointestinal pathologists. Histopathology. 2007;50:920–927.

Article  CAS  PubMed  Google Scholar 

Sangle NA et al. Overdiagnosis of high-grade dysplasia in Barrett’s esophagus: a multicenter, international study. Mod Pathol. 2015;28:758–765.

Article  PubMed  Google Scholar 

Krishnamoorthi R et al. Factors associated with progression of Barrett's esophagus: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2018;16:1046–1055 e8.

Shaheen NJ et al. Diagnosis and management of Barrett’s esophagus: an updated ACG guideline. Am J Gastroenterol. 2022;117:559–587.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Weusten B et al. Diagnosis and management of Barrett esophagus: European society of gastrointestinal endoscopy (ESGE) guideline. Endoscopy. 2023;55:1124–1146.

Article  PubMed  Google Scholar 

Parasa S et al. Development and validation of a model to determine risk of progression of Barrett's esophagus to neoplasia. Gastroenterology. 2018;154: 1282–1289 e2.

Rubenstein JH et al. AGA clinical practice guideline on endoscopic eradication therapy of Barrett’s esophagus and related neoplasia. Gastroenterology. 2024;166:1020–1055.

Article  PubMed  Google Scholar 

Duits LC. et al. Patients with Barrett's esophagus and confirmed persistent low-grade dysplasia are at increased risk for progression to neoplasia. Gastroenterology. 2017;152:993–1001 e1.

Song KY et al. Persistent confirmed low-grade dysplasia in Barrett's esophagus is a risk factor for progression to high-grade dysplasia and adenocarcinoma in a US Veterans cohort. Dis Esophagus. 2020;33.

Deo RC. Machine learning in medicine. Circulation. 2015;132:1920–1930.

Article  PubMed  PubMed Central  Google Scholar 

Taninaga J et al. Prediction of future gastric cancer risk using a machine learning algorithm and comprehensive medical check-up data: a case-control study. Sci Rep. 2019;9:12384.

Article  PubMed  PubMed Central  Google Scholar 

Shaheen NJ et al. Guideline to practice: diagnosis and management of Barrett’s esophagus: an updated ACG guideline. Am J Gastroenterol. 2022;117:1177–1180.

Article  PubMed  PubMed Central  Google Scholar 

Chandrasekar VT et al. Significantly lower annual rates of neoplastic progression in short- compared to long-segment non-dysplastic Barrett’s esophagus: a systematic review and meta-analysis. Endoscopy 2019;51:665–672.

Article  PubMed  Google Scholar 

Glamour BK et al. Age of diagnosis in familial Barrett’s associated neoplasia. Fam Cancer 2022;21:115–120.

Article  CAS  PubMed  Google Scholar 

Krishnamoorthi R et al. Risk of progression in Barrett's esophagus indefinite for dysplasia: a systematic review and meta-analysis. Gastrointest Endosc. 2020;91:3–10 e3.

Kambhampati S et al. Risk factors for progression of Barrett’s esophagus to high grade dysplasia and esophageal adenocarcinoma. Sci Rep. 2020;10:4899.

Article  CAS  Google Scholar 

Sharma P et al. The development and validation of an endoscopic grading system for Barrett’s esophagus: the prague C & M criteria. Gastroenterology. 2006;131:1392–1399.

Article  PubMed  Google Scholar 

Wani S et al. Patients with nondysplastic Barrett's esophagus have low risks for developing dysplasia or esophageal adenocarcinoma. Clin Gastroenterol Hepatol. 2011;9:220–7.

Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 2005;143:199–211.

Article  PubMed  Google Scholar 

Pudjihartono N et al. A review of feature selection methods for machine learning-based disease risk prediction. Front Bioinform. 2022;2:927312.

Article  PubMed  PubMed Central  Google Scholar 

Chawla NV et al. SMOTE: synthetic minority over-sampling technique. J Artif Int Res. 2002;16:321–357.

Google Scholar 

Murdoch WJ et al. Definitions, methods, and applications in interpretable machine learning. Proc Natl Acad Sci USA. 2019;116:22071–22080.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Siddique SM et al. the impact of health care algorithms on racial and ethnic disparities: a systematic review. Ann Intern Med 2024;177:484–496.

Article  PubMed  Google Scholar 

Sun H et al. Machine learning-based prediction models for different clinical risks in different hospitals: evaluation of live performance. J Med Internet Res. 2022;24:e34295.

Article  PubMed  PubMed Central  Google Scholar 

Shung DL et al. Validation of a machine learning model that outperforms clinical risk scoring systems for upper gastrointestinal bleeding. Gastroenterology 2020;158:160–167.

Article  PubMed  Google Scholar 

Iyer PG et al. Development of electronic health record-based machine learning models to predict Barrett’s esophagus and esophageal adenocarcinoma risk. Clin Transl Gastroenterol. 2023;14:e00637.

Article  PubMed  PubMed Central  Google Scholar 

Rubenstein JH et al. Validation and comparison of tools for selecting individuals to screen for Barrett’s esophagus and early neoplasia. Gastroenterology. 2020;158:2082–2092.

Article  PubMed  Google Scholar 

Giddings R et al. Factors influencing clinician and patient interaction with machine learning-based risk prediction models: a systematic review. Lancet Digit Health. 2024;6:e131–e144.

Article  CAS  PubMed  Google Scholar 

Pohl H et al. Length of Barrett’s oesophagus and cancer risk: implications from a large sample of patients with early oesophageal adenocarcinoma. Gut 2016;65:196–201.

Article  PubMed  Google Scholar 

Thota PN et al. Low risk of high-grade dysplasia or esophageal adenocarcinoma among patients with Barrett’s esophagus less than 1 cm (Irregular Z Line) within 5 years of index endoscopy. Gastroenterology. 2017;152:987–992.

Article  PubMed  Google Scholar 

Hamade N et al. Lower annual rate of progression of short-segment vs long-segment Barrett’s esophagus to esophageal adenocarcinoma. Clin Gastroenterol Hepatol. 2019;17:864–868.

Article  PubMed  Google Scholar 

Bergman J et al. An interactive web-based educational tool improves detection and delineation of Barrett's esophagus-related neoplasia. Gastroenterology. 2019;156:1299–1308 e3.

Wani S et al. Endoscopists systematically undersample patients with long-segment Barrett's esophagus: an analysis of biopsy sampling practices from a quality improvement registry. Gastrointest Endosc. 2019;90:732–741 e3.

Zellenrath PA et al. Neoplastic progression risk in females with Barrett's esophagus: a systematic review and meta-analysis of individual patient data. Clin Gastroenterol Hepatol. 2025;23:225–235 e8.